VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.) Co-Founder Professor David B. Weiner to Chair the First DNA Vaccines Conference in Asia

BLUE BELL, Pa.--(BUSINESS WIRE)--VGX Pharmaceuticals Inc. (VGX) announced today that Professor David B. Weiner of the University of Pennsylvania will serve as the Chairman of the DNA Vaccines Asia 2008 Conference next week in Seoul, Korea. Professor Weiner is a pioneer in the field of DNA vaccines and a VGX co-founder.